bioleaper회사는 제품 목록을 제공합니다.

회사 명:bioleaper

전화:-

이메일:guojing@bioleaper.com

국적:China

총 제품 수:5615

44 45 46 47 48 49 50 51 52 53 54 55 56 57

제품 카탈로그

Anti-DCBLD2 / ESDN Reference Antibody (FA19-1)
Anti-DC-SIGN / CD209 Reference Antibody (INSERM patent anti-DC-SIGN)
Anti-DCSTAMP Reference Antibody (U.Rochester patent anti-DC-STAMP)
Anti-DDR1 / CD167a Reference Antibody (Imperial College anti-DDR1)
Anti-DKK1 Reference Antibody (BHQ-880)
Anti-DLK1 Reference Antibody (LIV-1205)
Anti-DLL3 Reference Antibody (Dragonfly patent anti-DLL3)
Anti-FGFR1 / CD331 Reference Antibody (Lilly patent anti-FGFR-1)
Anti-FGFR2 / CD332 Reference Antibody (aprutumab)
Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab)
Anti-FGFR3 / CD333 Reference Antibody (LY3076226)
Anti-FGFR3 / CD333 Reference Antibody (vofatamab)
Anti-FGFR4 / CD334 Reference Antibody (U3-1784)
Anti-Fibronectin Reference Antibody (L19-TNF)
Anti-Fibronectin Reference Antibody (radretumab)
Anti-FLT3 / CD135 Reference Antibody (IMC-EB10)
Anti-FOLH1 / PSMA Reference Antibody (pelgifatamAb)
Anti-FOLH1 / PSMA Reference Antibody (rosopatamab)
Anti-DLL3 Reference Antibody (rovalpituzumab)
Anti-DLL4 Reference Antibody (demcizumab)
Anti-DLL4 Reference Antibody (enoticumab)
Anti-DLL4 Reference Antibody (navicixizumab)
Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4)
Anti-DPEP3 Reference Antibody (tamrintamab)
Anti-DPP4 / CD26 Reference Antibody (begelomab)
Anti-DSG3 Reference Antibody (Forerunner patent anti-DSG3)
Anti-Dysadherin Reference Antibody (Centrose patent anti-dysadherin)
Anti-E8L Antibody (NL_A151)
Anti-EFNA4 Reference Antibody (PF-06647263)
Anti-EGFL7 Reference Antibody (parsatuzumab)
Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147)
Anti-Endoglin / CD105 Reference Antibody (carotuximab)
Anti-ENTPD1 / CD39 Reference Antibody (TTX-030)
Anti-EpCAM / TROP1 / CD326 Reference Antibody (adecatumumab)
Anti-EpCAM / TROP1 / CD326 Reference Antibody (citatuzumab)
Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab)
Anti-EphA2 Reference Antibody (MEDI-547)
Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2)
Anti-EphA3 Reference Antibody (ifabotuzumab)
Anti-EphB2 Reference Antibody (Genentech patent anti-EphB2)
Anti-EphB4 Reference Antibody (Morphosys patent anti-EphB4)
Anti-EphB4 Reference Antibody (VasGene patent anti-EphB4)
Anti-EPOR Reference Antibody (Abbott patent anti-EPO Receptor)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (7A7)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (cetuximab)
Anti-FOLR1 Reference Antibody (Dompe patent anti-FOLR1)
Anti-FOLR1 Reference Antibody (farletuzumab)
Anti-FOLR1 Reference Antibody (mirvetuximab)
Anti-Fucosyl GM1 Reference Antibody (BMS-986012)
Anti-FZD Reference Antibody (vantictumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Chinese Mil.Med.Sci. patent anti-EGFR)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (demupitamab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Duke D2C7)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (imgatuzumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (laprituximAb)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (losatuxizumAb)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (matuzumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (modotuximab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (necitumumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (nimotuzumab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (pimurutamab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (tomuzotuximab)
Anti-ERBB1 / EGFR / HER1 Reference Antibody (zalutumumab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (gancotamab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (margetuximab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (timigutuzumab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab)
Anti-ERBB2 / HER2 / CD340 Reference Antibody (zanidatamab)
Anti-ERBB3 / HER3 Reference Antibody (barecetamab)
Anti-ERBB3 / HER3 Reference Antibody (seribantumab)
Anti-ERG Reference Antibody (Jackson Foundation patent anti-ERG)
Anti-ETBR Reference Antibody (DEDN6526A)
Anti-F11 / Factor XI Reference Antibody (abelacimab)
Anti-F11 / Factor XI Reference Antibody (osocimab)
Anti-F12 / Factor XII Reference Antibody (garadacimab)
Anti-F8 / Factor VIII Reference Antibody (Novo Nordisk patent anti-Factor VIII)
Anti-F9 / Factor IX Reference Antibody (emicizumab)
Anti-FAP Reference Antibody (sibrotuzumab)
Anti-FceR2 / CD23 Reference Antibody (lumiliximab)
Anti-FcgR2a / CD32a Reference Antibody (VIB9600)
Anti-FcgR3a / CD16a Reference Antibody (AFM13)
Anti-FcRL5 / IRTA2 Reference Antibody (cevostamab)
Anti-FcRL5 / IRTA2 Reference Antibody (DFRF4539A)
Anti-FcRn (FCGRT & B2M) Reference Antibody (batoclimab)
Anti-FcRn (FCGRT & B2M) Reference Antibody (nipocalimab)
Anti-FcRn (FCGRT & B2M) Reference Antibody (orilanolimab)
Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab)
Anti-FGF19 Reference Antibody (1A6)
Anti-FGF2 Reference Antibody (HuGAL-F2)
Anti-FGF23 Reference Antibody (burosumab)
Anti-ERBB3 / HER3 Reference Antibody (lumretuzumab)
Anti-ERBB3 / HER3 Reference Antibody (patritumab)

44 45 46 47 48 49 50 51 52 53 54 55 56 57